Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Temsirolimus and Sunitinib in Subjects With Advanced Renal Cell Carcinoma

NCT00417677 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.

NCT NCT00417677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Temsirolimus and Sunitinib in Subjects With Advanced Renal Cell Carcinoma
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 2007
Completion date
May 31, 2007
Enrollment
124
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma